20.03.2012 07:50 Uhr, Quelle: Wallstreet online

Astute Medical, Inc. Unveils Novel Test for Acute Kidney Injury

BRUSSELS, March 20, 2012 /PRNewswire/ - NephroCheck(TM) Test Aimed at Providing Risk Assessment Information for ICU Patients Astute Medical, Inc., a developer of biomarker-based diagnostics intended to aid physicians in managing critically …

Weiterlesen bei Wallstreet online